Mapreg
Le Kremlin Bicetre, FR· latest recorded location
MAPREG is named on 6 US grants and 9 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 6
- Published applications
- 9
- Inventors
- 9
- Granted in 2026 so far
- 0
- Most recent grant
- 3 Aug 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 2 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 1 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 1 | 1 |
By publication year.
Technology areas
Share of 15 documents
Recent patents
- Non-bioconvertible C3-substituted pregnenolone derivatives for use in the treatment of substance use disorders3 Aug 2021US 11,077,122 B2
- Method for treating a degenerative disease of the nervous system using 3-methoxy-pregnenolone or derivatives thereof18 Feb 2020US 10,561,671 B2
- Non-bioconvertible C3-substituted pregnenolone derivatives for use in the treatment of treatment-resistant depression17 Apr 2018US 9,943,528 B2
- Use of 3-methoxy-pregnenolone for the preparation of a drug for treating a traumatic brain injury17 May 2016US 9,339,508 B2
- Use of 3-methoxy-pregnenolone for the preparation of a drug for treating depressive disorders and long-term neurological diseases18 Dec 2012US 8,334,278 B2
- Non-bioconvertible c3-substituted pregnenolone derivatives for use in the treatment of substance use disorders21 Oct 2021US 2021/0322443 A1
- Non-bioconvertible c3-substituted pregnenolone derivatives for use in the treatment of substance use disorders8 Nov 2018US 2018/0318317 A1
- Non-Bioconvertible C3-Substituted Pregnenolone Derivatives for Use in the Treatment of Treatment-Resistant Depression7 Sep 2017US 2017/0252358 A1
- Method for treating a degenerative disease of the nervous system using 3-methoxy-pregnenolone or derivatives thereof16 Jun 2016US 2016/0166586 A1
- The use of 3-methoxy-pregnenolone for hte preparation of a drug for treating a traumatic brain inury14 Aug 2014US 2014/0228336 A2
Most cited
By later US patents
- Use of 3-methoxy-pregnenolone in the production of a medicament for treating neurodegenerative diseases23US 8,034,798 B22011
- Use of 3-methoxy-pregnenolone for the preparation of a drug for treating a traumatic brain injury7US 9,339,508 B22016
- Use of 3-methoxy-pregnenolone for the preparation of a drug for treating depressive disorders and long-term neurological diseases2US 8,334,278 B22012